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INTRODUCTION
Nerve growth factor (NGF) was the first neurotrophic agent to
be discovered and has become the paradigm of factors
preventing programmed cell death in selective populations of
neurones during the development of the central and peripheral
nervous systems (Levi-Montalcini, 1987). The trophic signals
elicited by NGF are transduced through its specific tyrosine
kinase receptor TrkA and modulated by the common
neurotrophin receptor p75 (p75NTR) (for a review, see Lewin
and Barde, 1996). The latter is a member of the Fas family of
cell death-inducing receptors and, like many other members of
this family, is able to induce apoptosis upon interaction with
its ligand, NGF, in cells lacking the expression of the trophic
receptor TrkA (Frade et al., 1996c; Frade and Barde, 1998,
1999; Frago et al., 1998; Casaccia-Bonnefil et al., 1996;
Davey and Davies, 1998; Soilu-Hänninen et al., 1999). The
proapoptotic action of NGF is not exclusive to this
neurotrophin. Brain-derived neurotrophic factor (BDNF) can
also induce apoptosis upon interaction with p75NTR in
postnatal sympathetic neurones, cells known to lack the
expression of the BDNF-specific trophic receptor, TrkB (Bamji
et al., 1998). Therefore, current opinion postulates that the
survival-promoting signals initiated by Trk receptors interfere
with the apoptosis-promoting signals of p75NTR (Dobrowsky
et al., 1995; Yoon et al., 1998). 
During the last few years, several signalling pathways have
been described for p75NTR in the absence of Trk receptors.
These include the induction of NF-kB and c-Jun kinase, the
production of ceramide, and the activation of tumour necrosis
factor receptor-associated factor 6 (TRAF6), p53 and a number
of caspases (Carter et al., 1996; Casaccia-Bonnefil et al., 1996;
Dobrowsky et al., 1994, 1995; Aloyz et al., 1998; Khursigara
et al., 1999; Gu et al., 1999; see Casaccia-Bonnefil et al., 1999
for a recent review). However, the mechanisms of activation
and signal transduction of p75NTR seem to differ from those of
Fas and tumour necrosis factor (TNF) receptors, probably due
to the different ligand binding requirements (trimeric ligands
of the TNF family versus dimeric neurotrophins) or to
structural differences in the death domain (see Cassacia-
Bonnefil et al., 1999). All these facts suggest that the
mechanism(s) employed by p75NTR to induce apoptosis could
be specific for this receptor when compared to the rest of
members of its family.
During the development of the central nervous system
(CNS), cell division typically occurs at the ventricular region
of the neuroepithelia. During the period of active neurogenesis,
some neuroblasts located in this zone enter the postmitotic state
(G0 phase) and then start migrating to their final destination.
These cells remain postmitotic throughout their phenotypic
maturation and their adult life. Thus, this critical transition
from the mitotic to the postmitotic state is highly regulated in
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During their early postmitotic life, a proportion of the
nascent retinal ganglion cells (RGCs) are induced to die as
a result of the interaction of nerve growth factor (NGF)
with the neurotrophin receptor p75. To analyse the
mechanisms by which NGF promotes apoptosis, an in vitro
culture system consisting of dissociated E5 retinal cells was
established. In this system, NGF-induced apoptosis was
only observed in the presence of insulin and neurotrophin-
3, conditions that favour the birth of RGCs and other
neurones expressing the glycoprotein G4. The pro-
apoptotic effect of NGF on the G4-positive neurones was
evident after 10 hours in vitro and was preceded by a
significant upregulation of cyclin B2, but not cyclin D1, and
the presence of mitotic nuclei in these cells. Brain-derived
neurotrophic factor prevented both the increase of cyclin
B2 expression in the G4-positive neurones and the NGF-
induced cell death. Finally, pharmacologically blocking
cell-cycle progression using the cyclin-dependent kinase
inhibitor roscovitine prevented NGF-induced cell death in
a dose-dependent manner. These results strongly suggest
that the apoptotic signalling initiated by NGF requires a
driving stimulus manifested by the neuronal birth and is
preceded by the unscheduled re-entry of postmitotic
neurones into the cell cycle.
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neuronal cells. This fine control is reflected in studies of the
retinoblastoma gene product, which has been shown in a
number of studies to arrest the cell cycle in late G1 phase
(Goodrich et al., 1991). Retinoblastoma-null mutant mouse
embryos present massive cell death in the CNS just outside the
ventricular area where postmitotic, migrating neurones can be
found (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992).
The observation of mitotic figures in the same regions as the
dying cells led Lee et al. (1992) to hypothesise that once a
neuroblast ended its normal period of cell division no further
re-entry into the cell cycle is allowed and, if the control of this
process breaks down the cell then dies. Along the same lines,
Herrup and Busser (1995) have shown that the induction of
multiple cell-cycle events precedes target-related neuronal
death in the CNS and ElShamy et al. (1998) associated the
death of dorsal root ganglion neurones with exit from the cell
cycle in neurotrophin-3 (NT3) null-mutant mice. These cells,
in the absence of NT3, fail to arrest the cell cycle and die in S
phase. In vitro support for the association between ectopic cell
division and cell death in the nervous system has been provided
by Freeman et al. (1994), who showed that the death of
cultured sympathetic neurones, triggered by NGF withdrawal,
leads to the accumulation of cyclin D1 (a G1 phase marker
known to activate cyclin-dependent kinase 4 (CDK4)/CDK6).
Moreover, Kranenburg et al. (1996) have shown that the
artificial elevation of cyclin D1 levels is sufficient to induce
apoptosis in neural and non-neural cell types. In addition,
the use of CDK inhibitors or dominant-negative forms of
CDK4/CDK6 promotes the survival of NGF-deprived
sympathetic neurones (Park et al., 1996, 1997a). Finally,
another cell-cycle progression marker that has been shown to
be upregulated during dopamine-triggered neuronal apoptosis
is cyclin B2 (Shirvan et al., 1997, 1998). Cyclin B2 is directly
involved in the transition from the G2 phase to mitosis,
activating CDK1/CDC2.
In the embryonic chick retina, a peak of apoptosis mediated
by NGF affects some p75NTR-positive cells. This peak
correlates with the active period of retinal ganglion cell (RGC)
neurogenesis (Frade et al., 1996c; Frade and Barde, 1998).
Interestingly, when BDNF was administered in ovo during the
period immediately prior to the peak of cell death, a significant
reduction in the amount of apoptosis was observed (Frade et
al., 1997), resulting in an increase in the number of postmitotic
RGCs. In addition, the number of nascent, premigratory RGCs
was not altered by BDNF treatment. These results strongly
suggest that the dying retinal cells, rescued by BDNF, were
postmitotic neurones in the process of migration to the vitreal
portion of the retina. 
We have investigated whether the cell death initiated by
p75NTR upon binding to NGF is preceded by the upregulation
of components required for cell-cycle progression in newborn,
postmitotic neurones. To test this hypothesis, an in vitro system
consisting of dissociated E5 retinal cells cultured on laminin-
1 in the presence of 1 m M insulin and 0.1 nM NT3 was used.
These conditions induce the birth of G4-positive neurones (de
la Rosa et al., 1994; Frade et al., 1996a,b), a subset of retinal
cells that includes RGCs and some amacrine neurones, and are
known to express p75NTR (Von Bartheld et al., 1991). This
model system has enabled us to show that exposure to NGF
induced apoptosis in retinal cells only in the presence of insulin
and NT3. This was preceded by the increase of cyclin B2 and
the presence of mitotic figures in G4-positive neurones. The
re-entry into the cell cycle appears to be involved in the
induction of apoptosis since BDNF diminished the presence of
cyclin B2 in G4-positive neurones and then rescued cell death.
Moreover, the pharmacological blockage of the G2/M
transition was able to prevent NGF-induced cell death.
MATERIALS AND METHODS
Chick embryos
Fertilised eggs from White Leghorn hens were obtained from a local
supplier and were incubated at 38.5°C in an atmosphere of 70%
humidity. The embryos were staged according to Hamburger and
Hamilton (1951).
Antibodies
The mAb G4 labels a glycoprotein located on neurites of a subset of
differentiated neurones (Rathjen et al., 1987). It stains 10-12% of
differentiated neurones in dissociated cultures from the E9 chick
retina. These neurones include retinal ganglion cells and a population
of neurones in the inner nuclear layer (Frade et al., 1996b). The
monoclonal antibody 27/21 (used here at 120 ng/ml) specifically
blocks the biological activity of NGF, as reported elsewhere
(Korsching and Thoenen, 1987). The rabbit polyclonal antiserum
#9651, made against the extracellular domain of mouse p75NTR
(amino acids 43-161) as a GST-2T fusion protein (Huber and Chao,
1995), was a generous gift from M. V. Chao (New York, USA). This
antibody blocks binding of 125I-NGF to rat or mouse p75NTR in
affinity crosslinking assays (1:100 dilution). The rabbit polyclonal
antiserum R18 raised against chick cyclin B2 has been described
elsewhere (Gallant and Nigg, 1992) and was a generous gift of E. A.
Nigg (Geneva, Switzerland). The affinity-purified rabbit polyclonal
antibody H-295 (Santa Cruz Biotecnology) was raised against a
recombinant protein corresponding to amino acids 1-295, representing
the full-length cyclin D1 of human origin.
Preparation of retinal cells and cell cultures
Retinas from E5 embryos were dissected free from pigment epithelium
and dissociated as described previously (Rodríguez-Tébar et al., 1989;
de la Rosa et al., 1994). Dissociated cells were suspended in culture
medium and plated (20,000 cells/cm2) on 10-mm round glass coverslips
into four-well dishes (Greiner). The coverslips were previously coated
with polyornithine (Sigma)/laminin-1 (Gibco BRL) (Collins, 1978).
Cells were cultured in 50% DMEM/50% F12 HAM (Sigma) with the
N2 supplements (Bottenstein and Sato, 1979) lacking insulin where
indicated. Cultures were maintained at 37°C in a water-saturated
atmosphere containing 5% CO2. Where mentioned, cultures were
supplemented with recombinant b -NGF, BDNF, NT3 (a generous gift
of Y.-A. Barde; Martinsried, Germany) or 7S NGF (Boehringer
Mannheim). 7S NGF (Varon et al., 1967) is an a 2 b 2 g 2 complex in
which the b -NGF dimer is associated with two a -NGF and two g -NGF
subunits, which belong to the glandular kallikrein family of serine
proteinases. The g -NGF subunit is an active serine proteinase capable
of processing the precursor form of b -NGF, whereas a -NGF is an
inactive serine proteinase. b -NGF and 7S NGF were used at the
concentrations mentioned in the text and both showed equivalent
results, therefore both will be called NGF hereafter. BDNF and NT3
were used at 0.1 nM. Roscovitine (Calbiochem) was prepared at 10 mM
in dimethylsulfoxide (DMSO) and then diluted in culture medium to
the final concentrations of 1-50 m M. At this range of concentration,
roscovitine is a known specific inhibitor of CDK1/CDC2, CDK2 and
CDK5 (Meijer et al., 1997; De Azevedo et al., 1997). 
Quantification of apoptosis and mitotic numbers
Cell counting was carried out on a Zeiss Axiophot microscope with
J. M. Frade
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phase contrast and epifluorescence illumination. At least 5% of the
total number of cells was observed per culture and each experimental
point was the average ± s.e.m. of at least three cultures. To
characterise apoptosis by morphological criteria, DNA was labelled
with 1 m g/ml bisbenzimide (Sigma) in 4% paraformaldehyde-fixed
cells and the number of pyknotic nuclei was established. Apoptotic
cells were also detected by using terminal deoxynucleotidyl
transferase-mediated dUTP nick end labelling (TUNEL) (in situ cell
death detection kit, POD; Boehringer Mannheim), following the
manufacturer’s instructions. TUNEL yielded similar results to those
obtained by morphological criteria (data not shown). Mitotic nuclei
were identified by bisbenzimide labelling. Due to the low percentage
of mitotic nuclei present in the cultures, at least half of the total cells
were observed and, when possible, over 50 mitotic nuclei were
counted per culture. 
Cell staining
For immunocytochemistry, cultured cells were incubated for 20
minutes at room temperature in a 400-fold dilution of ascites fluid
containing G4 mAb in Krebs-Ringer-Hepes (KRH) buffer. Cells were
then subjected to two successive incubations of 20 minutes each in a
400-fold dilution in KRH of biotinylated anti-mouse Ig antibody
(Jackson) and a 400-fold dilution of streptavidin-Alexa 568
(Molecular Probes). Washing steps with KRH were performed after
each single incubation. Finally, cells were fixed for 20 minutes in 4%
paraformaldehyde. For double staining with G4 mAb and an
additional rabbit polyclonal antiserum, the previous protocol was
extended as follows. Fixed cells were washed in PBS and
permeabilised in PBS/0.5% Triton X-100 (PBTx) for 15 minutes.
Then, they were incubated in PBTx containing the respective
antiserum (1:600, anti-cyclin B2; 2 m g/ml, anti-cyclin D1) and, finally,
incubated in a 4000- or 400-fold dilution of anti rabbit coupled to
Alexa 488 (Molecular Probes) in PBTx respectively. Washes with
PBTx were intercalated among the incubations with antibodies. Cells
were then mounted in PBS/glycerol.
Neurogenesis assay
Neuron differentiation in vitro was studied as previously described
(Frade et al., 1996a). Briefly, culture medium contained 0.5 m Ci/ml
[3H]methyl thymidine (25 Ci/mmol; Amersham International). After
20 hours incubation, retinal cells were labelled with G4 mAb and
exposed for thymidine autoradiography for 2-3 days. Cells that were
G4-positive/thymidine-positive were those that had proliferated as
neuroepithelial cells and converted to neurons in vitro. 
Fig. 1. Induction of cell death by NGF. E5 retinal cells
were cultured on laminin-1 in a chemically defined
medium containing 1 m M insulin and 0.1 nM NT3 for 18
hours in the presence or absence of NGF. Apoptosis was
analysed by staining with bisbenzimide (A,B). (C,D) The
bright field corresponding to A and B, respectively. Note
how pyknotic nuclei (arrows) are easily observed in
cultures in the presence of NGF, and the presence of a
mitotic nucleus (arrowhead). The percentage of pyknotic
nuclei was quantified in cells cultured with 1.5 nM NGF
(E). Basal levels of cell death were observed in control
cultures. This value was significantly increased in the
presence of 1.5 nM NGF (- ), an effect that was reversed by
anti-p75NTR polyclonal antiserum #9651 (Huber and Chao,
1995) (a -p75) used at 1:300 dilution (left) or 1:1000
(right), or the anti-NGF mAb 27/21 (Korsching and
Thoenen, 1987) (a -NGF) used at 120 ng/ml. The effect of
NGF was saturating at 1.5 nM, as observed in (F). The
apoptotic effect of 1.5 nM NGF was delayed in time and
significant levels of apoptosis were not observed before 10
hours in vitro (G). Values are means ± s.e.m. (n=4).
(*P<0.05;**P<0.005; Student’s t-test). Bar, 30 m m.
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Image analysis
Quantification of cyclin expression levels was performed as follows.
Staining of cyclin D1 and cyclin B2 was all performed on one
occasion to eliminate effects of different batches of reagents. Fields
showing cyclin/G4 double immunolabelled neurones were randomly
selected and digitalised using confocal microscopy (Leica). The
cyclin B2 or cyclin D1 signal per each G4-positive cell was then
quantified using the Q500 MC QWin software (Leica, version
V01.01). Final values were obtained by multiplying the intensity of
signal by the total area and then the average was normalised to 1 in
controls. Final values were distributed into arbitrary intervals and
the frequency of these values in each interval was plotted as a
function of density. 
RESULTS
NGF induces cell death in cultured E5 retinal cells
During the main onset of neurogenesis (E5-E7) a number of
retinal neurones that have left the cell cycle and are migrating
to their neuronal layer are induced to die by NGF in vivo
(Frade et al., 1996c, 1997). To gain an insight into the
mechanism used by NGF to induce apoptosis, precursor cells
isolated from E5 retinas were cultured on laminin-1 in a
chemically defined medium containing 1 m M insulin and 0.1
nM NT3 as described previously (Frade et al., 1996a,b).
Insulin used in the micromolar range is likely to be acting on
insulin-like growth factor (IGF)-I receptors, thus mimicking
the differentiative effect of IGF-I on the E5 retinal cells, as
previously described (Frade et al., 1996b). After 18 hours in
the absence of NGF, control cultures showed spontaneous cell
death in about 7% of the total cells, as detected by the
evaluation of pyknotic nuclei using TUNEL (not shown) or
bisbenzimide (Fig. 1). When 1.5 nM NGF was added, the
proportion of dying cells was significantly increased to
around 14% (Fig. 1). This cell death-promoting effect was
abolished by treatment with an anti-NGF mAb or an anti-
p75NTR polyclonal antiserum (Fig. 1E), indicating that NGF
specifically induced cell death. The half-maximal induction
of cell death was obtained at about 0.15 nM NGF and the
maximal effect was reached with 1.5 nM NGF (Fig. 1F). The
induction of apoptosis by NGF was not apparent before 10
hours and the effect was maximal after 14 hours (Fig. 1G).
This delay of several hours in the apoptotic response to NGF
suggests that an indirect mechanism is necessary for the
transduction of the p75NTR-mediated signal, such as the
expression of chemical mediators by the cultured cells (see
below).
The absence of neurogenesis-promoting conditions
abolishes cell death in cultured E5 retinal cells
The removal of insulin and NT3 from the culture medium used
in this study results in the abolition of the genesis of G4-positive
neurones (de la Rosa et al., 1994; Frade et al., 1996b). Fig. 2A
shows the effect of different combinations of these factors on
neurogenesis, measured as described in Materials and Methods.
In the absence of insulin, a block of the genesis of G4-positive
neurones occurred, even in the presence of NT3. Insulin itself
had a small amount of neurogenic activity, which was highly
enhanced by NT3. This profile correlated with the levels of
apoptosis induced by NGF in the presence of such combinations
of factors (Fig. 2B), suggesting that NGF might execute its
killing action on precursor cells committed to become G4-
positive neurones. To test this idea the percentage of G4-positive
neurones remaining in NT3/insulin-containing cultures in the
presence or absence of NGF was quantified after 18 hours. This
analysis showed a significant decrease in the proportion of these
neurones in NGF-treated cultures (Fig. 3A), suggesting that G4-
positive neurones are targets of NGF. Cells with pyknotic nuclei
harbouring the G4 antigen on their membrane were not observed
in the NGF-treated cultures, probably due to the loss of this
particular marker from the cell membrane in apoptotic cells.
Nevertheless, dying cells expressing cytoplasmic G4 antigen
were frequently observed in cultures treated with NGF,
suggesting that G4 was somehow translocated from the cell



























































Fig. 2. NGF-induced cell death depends on neurogenesis-promoting
conditions. (A) Presence of 1 m M insulin and 0.1 nM NT3 enhances
the production of G4-positive cells after 20 hours in vitro. This
parameter is evaluated as the proportion of G4-positive cells that
have incorporated [3H]methyl thymidine during the time in vitro.
Values are means ± s.e.m. (n=3). (B) E5 retinal cells were cultured
for 18 hours in the presence of 1.5 nM NGF or in the absence of this
factor, and apoptosis was estimated by counting pynotic nuclei. Note
that the induction of apoptosis by NGF was only observed in the
presence of 1 m M insulin and 0.1 nM NT3, conditions that favour the
genesis of G4-positive neurones. Values are means ± s.e.m. (n=4).
(*P<0.01, **P<0.001; Student’s t-test).
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NGF induces unscheduled cell-cycle events before
the onset of cell death in vitro
In an attempt to understand the molecular basis underlying the
proapoptotic effect of NGF on retinal cells, we postulated that
this factor could trigger cell death in G4-positive postmitotic
neurones by inducing them to re-enter the cell cycle. Indeed, an
emerging view considers the process of neuronal apoptosis as a
consequence of unscheduled and unsynchronised induction of
cell-cycle mediators (see Introduction). As a first approximation
to establish a relationship between NGF-induced cell death and
re-entry into the cell cycle, the percentage of mitotic figures
present in control versus NGF-treated cultures was estimated at
a time point when cell death is just starting (10 hours) (Fig. 1G).
The proportion of cells showing colocalisation of mitotic figures
with the neuronal marker G4 was dramatically increased in
NGF-treated cultures (Figs 3B, 4), suggesting that the presence
of NGF forced these neurones to re-enter the cell cycle. 
Nevertheless, there are two alternative interpretations of these
results, and these were tested experimentally. One possibility is
that NGF could force proliferation that would be immediately
followed by differentiation, explaining why some G4-positive
cells showed mitotic nuclei. To rule out this possibility we
carefully dissociated E5 chick retinas and the resulting single
cell suspensions were diluted in culture medium. Then, cells
were plated at low density (5,000 cells/cm2) and cultured for 10
hours. Under these conditions cells proliferate as in cultures at
higher cell density (not shown). If NGF induced one round
of cell division and then neuronal differentiation (i.e. G4
expression), one would expect the cell clumps containing
G4-positive neurones to be larger in the presence of this
neurotrophin. After 10 hours in vitro, the size of cell clumps
containing G4-positive neurones was similar both in the absence
(1.43±0.11 cells/clump; n=70 clumps) or presence of NGF
(1.30±0.09 cells/clump; n=70 clumps). These data indicate that
this neurotrophin did not induce proliferation and subsequent
expression of the neuronal marker G4. An additional
interpretation for the presence of cells in which mitotic nuclei
and the neuronal marker G4 colocalise is that NGF could force
the expression of the G4 antigen in mitotically active retinal
precursors. To rule out this possibility we again used the low-
density cultures mentioned above. If NGF induced G4
expression in the retinal precursors, one would expect an
increase in the proportion of cell clumps containing G4-positive
neurones. The percentage of cell clumps containing at least one
G4-positive cell was unchanged by the treatment with NGF
(9.16±0.23%; n=4 cultures) when compared to the control
situation (9.32±0.43%; n=4 cultures), indicating that NGF did
not induce G4 expression in retinal precursors. All these results
further confirmed the interpretation that NGF induced re-entry
into the cell cycle in the G4-positive neurones. 
To investigate the molecular basis of this effect we analysed
the expression of two representative cyclins, cyclin D1 and cyclin
B2, in the G4-positive neurones after 10 hours in vitro. Cyclin
D1 is involved in the progression from the G1 phase to S phase,
whereas cyclin B2 acts at the level of the G2/M transition. As
mentioned above, the upregulation of these two molecules is an
early landmark during neuronal death initiated under different
physiological and experimental situations (Freeman, 1994;
Kranenburg et al., 1996; Shirvan et al., 1997; 1998). Cultures in
the presence and absence of 1.5 nM NGF were immunostained
with an anti-G4 mAb, and then with specific antisera against
these two cyclins. A basal expression of both molecules was seen
in most of the G4-positive cells even in control cultures (Fig. 5).
Due to the fluctuating expression of these molecules during the
cell cycle it was impossible to establish a baseline below which
a cell could be unambiguously classified as cyclin-negative. In an
attempt to solve this problem, the levels of both cyclins expressed
by the G4-positive cells were quantified in both control and NGF-
treated cultures by means of image analysis (see Materials and
Methods). The mean intensity of cyclin D1 expressed by the G4-
positive neurones was unchanged upon treatment with NGF
(Table 1). On the contrary, the mean intensity of cyclin B2
expressed by G4-positive neurones was slightly, but significantly,
increased in the presence of NGF (Table 1). This result was
confirmed by a clear increase in the frequency of G4-positive
neurones expressing high levels of cyclin B2 (Fig. 6). The time
point at which the study was performed (10 hours) preceded the
period of maximum cell death, suggesting that the upregulation
of cyclin B2 might be part of the early events that cause apoptosis
induced by NGF in this culture system. 
BDNF reverses unscheduled cell-cycle events and
rescues neurones induced to die by NGF
BDNF has been shown to rescue cell death in chick retinas in
vivo (Frade et al., 1997). In vitro, 0.1 nM BDNF was able to
prevent the apoptotic effect of 1.5 nM NGF on retinal cells
cultured for 18 hours (Fig. 7). Importantly, 0.1 nM BDNF
decreased the mean intensity of cyclin B2 expressed by the G4-
positive neurones cultured in presence of NGF for 10 hours
(Table 1). This result suggested that the upregulation of cyclin
B2 represented an early step involved in the induction of cell
death by NGF. Nevertheless, the crucial experiment to support
this assumption would be the analysis of the blockage of cell-
cycle progression in terms of cell death.
Blockage of cell-cycle progression inhibits the
proapoptotic effect of NGF











































Fig. 3. Effect of NGF in G4-positive neurones. (A) 1.5 nM NGF
present in cultures of E5 retinal cells under conditions promoting
neurogenesis induced a decrease in the final number of neurones
generated in vitro, probably due to the induction of apoptosis. Values
are means ± s.e.m. (n=2). (B) 1.5 nM NGF increased the proportion
of G4-positive neurones showing mitotic nuclei. Values are means ±
s.e.m. (n=4). (*P<0.01; **P<0.001; Student’s t-test).
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NGF in G4-positive neurones might be involved in the induction
of cell death by this neurotrophin, cell-cycle progression was
pharmacologically blocked by the CDK-inhibitor roscovitine
and the consequences of this blockage in terms of apoptosis were
studied. Roscovitine, added to NGF-treated cultures for 18 hours
at concentrations that specifically affect CDK1/CDC2, CDK2
and CDK5 (de Azevedo et al., 1997; Meijer et al., 1997), was
able to reduce the proportion of apoptotic cells in a dose-
dependent manner (Table 2). Therefore, the simultaneous
blockage of cell death and cell proliferation by roscovitine
supported the hypothesis that the pro-apoptotic action of NGF
implied, at least in part, the re-entry into the cell cycle of
postmitotic neurones. Roscovitine executed its anti-apoptotic
effect presumably through the inhibition of the cyclin B2-
dependent kinase (CDK1/CDC2), although additional effects via
blockage of altenative kinases (see Maas et al., 1998) cannot be
ruled out. Roscovitine used at 50 m M induced an apparent drop
of viability, as previously shown by Maas et al. (1998). These
authors suggested that this effect was probably due to solvent
toxicity since this CDK inhibitor was prediluted in DMSO
before the final dilution in medium. To test this hypothesis, E5
retinal cells were cultured in the presence of NGF with DMSO
at the same concentration as used with 50 m M roscovitine. Such
a treatment did not augment the levels of pyknotic cells (Table
2), suggesting that the deleterious effect of 50 m M roscovitine
was due to the CDK inhibitor and not to the solvent. Indeed, 50
m M roscovitine was able to induce pyknotic nuclei in control
cultures (Table 2), indicating that at high concentrations,
roscovitine could have pleiotropic effects that compromise
cellular survival.
DISCUSSION
In this article we show that NGF is capable of inducing apoptosis
of postmitotic neurones that express the neuronal marker G4.
This induction of apoptosis is accompanied by an increase of
cyclin B2, which is constitutively expressed at low levels by
these cells, and re-entry into the cell cycle. BDNF prevents NGF-
induced cell death and simultaneously decreases the level of
cyclin B2 in G4-positive cells treated with NGF. Finally,
blocking cell-cycle progression by means of the cyclin-
dependent kinase inhibitor roscovitine prevents NGF-induced
cell death. 
NGF induces cell death in postmitotic neurones
During the early developmental stages of the chick retina, a
number of RGC neurones that have left the cell cycle and started
migrating towards their adult layer suffer apoptosis induced by
NGF upon its interaction with p75NTR (Frade et al., 1996c,
1997). This conclusion has been corroborated in null mutant
mice for ngf or p75NTR (Frade and Barde, 1999). In this article
we have used an in vitro system to analyse apoptotic signals
triggered by p75NTR upon binding to NGF. As such, dissociated
cells from E5 chick retina were cultured under conditions that
have previously been shown to induce the birth of G4-positive
neurones (de la Rosa et al., 1994; Frade et al., 1996a,b). This
neuronal subpopulation is composed of RGCs and neurones
located at the vitreal region of the inner nuclear layer (Frade et
al., 1996b), all of them known to express p75NTR (Von Bartheld
et al., 1991). The neurogenesis-promoting conditions mentioned
above are characterised by the presence of 1 m M insulin and 0.1
nM NT3 in the culture medium (de la Rosa et al., 1994; Frade
et al., 1996b). When NGF was added to this assay an increase
in cell death was observed. The induction of cell death was
specific for NGF since a previously described mAb that inhibits
the biological activity of NGF (Korsching and Thoenen, 1987)
blocked the pro-apoptotic effect of this neurotrophin. In addition,
the induction of cell death was dose dependent, reaching its
maximum at 1.5 nM NGF, thus resembling the data obtained by
Davey and Davies (1998) for the induction of apoptosis by NGF
in neurones of the trigeminal mesencephalic nucleus. The time
course over which NGF exhibits its effect indicated a delay of
10 hours in triggering cell death. This contrasts with the data
obtained from mature oligodendrocytes where more rapid
kinetics were found (Cassacia-Bonnefill et al., 1996). In this
respect, our data resemble more closely those obtained by Davey
and Davies (1998), who observed the effect of NGF after 48
hours in vitro. The delay observed in the induction of apoptosis
could be explained by the involvement in the downstream
signalling of the upregulation of cyclin B2 (see below). The pro-
apoptotic effect of NGF was clearly mediated by p75NTR since
a polyclonal antiserum generated against the extracellular
domain of mouse p75NTR (Huber and Chao, 1995) was able to
block the killing action of NGF. 
J. M. Frade
Fig. 4. Mitotic and pyknotic nuclei in G4-positive cells treated with
NGF. Cultures in the presence of 1.5 nM NGF were fixed after 10
hours and immunostained with the anti-G4 mAb (A) and then with
bisbenzimide (B). This latter method revealed the existence of G4-
positive neurones with mitotic nuclei (arrow). Cells showing
pyknotic nuclei (arrowhead in B) were also positive for the G4
antigen (arrowhead in A) (see Fig. 3B) but the signal was mainly
located in the cytoplasm, suggesting that the apoptotic process
induced a relocation of the G4 from the nucleus to the cytoplasm.
Bar, 10 m m. 
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Three lines of evidence led us to conclude that NGF was
responsible for the death of postmitotic neurones in our system.
First, neurogenesis-promoting conditions (de la Rosa et al.,
1994; Frade et al., 1996a,b) were necessary for NGF to induce
apoptosis. Thus, the removal of insulin and NT3 prevented the
pro-apoptotic effect of NGF. Second, NGF reduced the
proportion of G4-positive neurones concurrently with the
induction of apoptosis. And, third, cells positive for the G4
antigen could be observed harbouring pyknotic nuclei in NGF-
treated cultures. There are many examples in the literature where
cells induced to die by NGF are postmitotic and express high
levels of p75NTR, for instance, long-term cultures of mature
postmitotic oligodendrocyes (Casaccia-Bonnefil et al., 1996),
postnatal rat sympathetic neurones during the developmental
period of naturally occurring cell death (Bamji et al., 1998) and
neurones of the trigeminal mesencephalic nucleus of chick E10
embryos (Davey and Davies, 1998).
Furthermore, NGF-induced cell death has
also been described in the mouse spinal
cord where p75NTR is also expressed by
differentiated cells (Frade and Barde,
1999). All these data suggest that NGF
could exert its pro-apoptotic effect mainly
on postmitotic neural cells.
Cell-cycle re-entry as a common
early feature of neuronal cell death
One of the main features of the nervous
system is that their principal cellular
constituents become postmitotic at a
specific moment during their development
and remain quiescent the rest of their adult
life. Keeping this in mind, it is not unusual
that any perturbation inducing the re-entry
into the cell cycle in a neurone would
result in a regulatory conflict that may be
translated into the death of the cell. So far,
many reports have shown that apoptosis in
cells of neural origin operates through the
upregulation of molecules involved in
cell-cycle progression, frequently in a
disorganized manner (Freeman et al.,
1994; Herrup and Busser, 1995;
Kranenburg et al., 1996; Shirvan et al.,
1997; ElShamy et al., 1998). This can be
prevented by agents that block cell-cycle progression (Park et
al., 1997a,b; Markus et al., 1997; Maas et al., 1998). Therefore,
Fig. 5. NGF increases the proportion of cells
expressing cyclin B2, but not cyclin D1. E5
retinal cells were cultured for 10 hours in
neurogenic conditions in the absence
(A,C,E,G) or presence (B,D,F,H) of 1.5 nM
NGF and then immunostained for the
neuronal marker G4 (arrows in C,D,G,H).
Cultures were then subjected to
immunostaining using specific antisera
directed against cyclin D1 (A,B) or cyclin B2
(E,F) (see Materials and Methods). The
proportion of G4-positive cells that expressed
high levels of cyclin B2 increased in cultures
treated with NGF (for quantification, see Fig.
6). Cyclin D1 levels were not affected by this
treatment. Bar, 30 m m.
Table 1. Upregulation of cyclin B2 levels in the G4-positive
neurones induced by NGF
Treatment Cyclin D1 Cyclin B2
Control 1.00±0.05 (19) 1.00±0.08 (48)
NGF 1.04±0.10 (14) 1.36±0.10 (43)*
NGF/BDNF n.d. 0.91±0.08 (49)
E5 retinal cells were cultured for 10 hours in neurogenic conditions and
then the level of cyclin D1 and cyclin B2 expressed by the G4-positive
neurones were quantified by means of image analysis (see Materials and
Methods). 
Average values from individual data were normalised in the control
situation. Values are means ± s.e.m. (n); (*P<0.01; Student’s t-test). 
n.d., not determined.
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the emergent concept of unscheduled cell-cycle re-entry as a
general cause of neuronal cell death is becoming accepted in the
field. In the present report we have shown that the unscheduled
induction of cell-cycle events also precedes the cell death caused
by NGF in retinal postmitotic neurones. Thus, we demonstrated
an increase of mitotic nuclei associated with G4-positive cells in
NGF-treated cultures before NGF-induced apoptosis becomes
apparent. Although not directly demonstrated, this effect was
likely to be mediated by p75NTR since TrkA, the alternative
known receptor of NGF, has not been detected in the retinal cells
at this particular developmental stage (Frade et al., 1996c). The
fact that p75NTR is known to be expressed only by postmitotic
retinal neurones (Von Bartheld et al., 1991) is consistent with the
increase in mitotic nuclei taking place exclusively in these cells. 
Among the different regulators of cell-cycle progression
presumably being affected by NGF, the G2/M phase-specific
cyclin B2 was found to be upregulated in the G4-positive
neurones before the onset of cell death. Again, although not
directly demonstrated, this effect was likely to be mediated by
p75NTR since TrkA has not been detected in the E5 retinal cells
(Frade et al., 1996c). The upregulation of cyclins is one early
and critical step that occurs during apoptotic cell death of neural
cells. Cyclin B2 has been shown to present a double wave of
transcriptional upregulation when sympathetic neurones are
induced to die by treatment with dopamine (Shirvan et al., 1997).
This cyclin is a known activator of CDK1/CDC2, which is
considered to be a major target of the molecular mechanisms
involved in the establishment of quiescence in neuronal
precursors. Indeed, deregulation of the mechanisms monitoring
the activity of CDK1/CDC2 can lead to apoptosis in higher
eukaryotic cells (Fotedar et al., 1995; Shimizu et al., 1995).
CDK1/CDC2 immunoreactivity has been detected in avian
postmitotic RGCs (Espanel et al., 1997), thus making possible
its interaction with cyclin B2 in those neurones that upregulate
this cyclin. In the future, it will be necessary to analyse whether
the rather modest increase of cyclin B2 levels induced by NGF
(around 30%) is sufficient to induce a substantial rise in
CDK1/CDC2 activity. Interestingly, cyclin D1, a known G1
marker, was also expressed in many cells including those
positive for G4, but did not show any change in its protein levels
after treatment with NGF. This was reminiscent of dopamine-
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Table 2. NGF-induced cell death is abolished by the cyclin-
dependent kinase inhibitor roscovitine
Treatment n Total cells Pyknotic cells (%)
Control 6 32,695±909 2,229±149 (6.82)
50 m M roscovitine 3 18,271±679*** 3,608±134*** (19.75)
NGF 6 32,513±1,373 4,285±257*** (13.18)
NGF/1 m M roscovitine 3 32,770±163 5,206±676*** (15.89)
NGF/5 m M roscovitine 3 27,652±1,350* 2,679±172 (9.69)
NGF/25 m M roscovitine 3 21,965±1,554*** 1,682±202 (7.66)
NGF/50 m M roscovitine 3 21,476±94*** 6,061±1,089** (28.22)
NGF/DMSO 3 31,875±957 3,866±83*** (12.13)
E5 retinal cells were cultured for 18 hours in neurogenic conditions and
stained with bisbenzimide, and the final number of cells and the number of
pyknotic cells per culture were estimated. As expected, 1.5 nM NGF (NGF)
induced cell death when added to the cultures. This effect was inhibited in a
dose-dependent manner by the addition of roscovitine, dissolved in DMSO, at
a range of concentrations that specifically inhibit CDK1/CDC2, CDK2 and
CDK5 (de Azevedo et al., 1997; Meijer et al., 1997). The presence of
roscovitine was also able to reduce the final number of cells in a dose-
dependent manner. Note that 50 m M roscovitine caused an apparent decrease
in viability even in the absence of NGF (see text). This effect was specific for
the drug, since DMSO at the same concentration as used with 50 m M
roscovitine did not show any effect on cell death. 
Values are means ± s.e.m. *P<0.01, **P<0.005, ***P<0.001; Student’s t-
tests carried out with respect to control cultures).
Values in parentheses are percentage of total.
cyclin B2 expression level












Fig. 6. Expression levels of cyclin B2 in control and NGF-treated
cultures. E5 retinal cells were cultured for 10 hours in neurogenic
conditions in the absence (s) or presence (d) of 1.5 nM NGF and
then double-immunostained for the neuronal markers G4 and cyclin
B2 (see Fig. 5). Random fields were digitalised and the level of
cyclin B2 staining was quantified in at least 40 G4-positive neurones
(see Materials and Methods). These values were distributed
arbitrarily over 11 intervals of similar size from the lowest level (0)
to the highest level (10) of expression of cyclin B2. Finally, the
frequency at which the various levels of cyclin B2 were distributed in
the different intervals was plotted as a function of density. Note that
the distribution of frequencies changed in the presence of NGF such
that the cells containing higher levels of cyclin B2 were much more
frequent than those with lower levels of this cyclin. The difference
between the mean control values and those from the NGF-treated
cultures was statistically significant (see Table 1). 



























Fig. 7. BDNF inhibits the induction of cell death by NGF. E5 retinal
cells were cultured for 18 hours in neurogenic conditions, stained
with bisbenzimide and the proportion of pyknotic cells was
estimated. As expected, 1.5 nM NGF significantly induced cell death
when added to the cultures. This effect was inhibited by the addition
of 0.1 nM BDNF. Values are means ± s.e.m. (n=3). (*P<0.01;
Student’s t-test).
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triggered cell death in sympathetic neurones where cyclin D1,
unlike cyclin B2, was not re-expressed (Shirvan et al., 1997). 
The correlation between the cell-cycle events mentioned
above and the cell death triggered by NGF in the G4-positive
neurones suggest that this neurotrophin causes apoptosis, at least
in part, through the unscheduled induction of cell-cycle events
in postmitotic neurones. This assumption is further supported by
the inhibition of NGF-dependent cell death by blocking cell-
cycle progression using the purine analogue, roscovitine. This
compound is a potent and selective inhibitor of CDK1/CDC2,
CDK2 and CDK5 (de Azevedo et al., 1997; Meijer et al., 1997).
Roscovitine was able to reverse the pro-apoptotic effect of NGF.
Further support that cell-cycle events are related to NGF-induced
cell death derive from the reduction in the proportion of mitotic
nuclei and cyclin B2 upregulation in G4-positive neurones when
BDNF is used to block NGF-induced apoptosis. Therefore, these
results illustrate the importance of the aberrant re-entry into cell
cycle as a crucial step in the induction of cell death by NGF. The
question as to whether over-expression of cyclin B2 in retinal
cells induces them to die remains to be studied, possibly
providing further evidence that the expression of cyclins in
neurones induces their death, previously demonstrated in
different neuronal systems (see Introduction).
It is interesting that both cyclin D1 and cyclin B2 remained
expressed at low levels in most G4-positive neurones in vitro.
The expression of cell-cycle progression markers in mature
neurones has been described previously. As such, CDK1/CDC2
has been shown to be expressed by postmitotic RGCs and to
exhibit a temporal pattern of expression similar to cyclin A and
cyclin B2 in the avian retina (Espanel et al., 1997). CDK5 is
mainly expressed at adult stages in the mouse forebrain (Tsai et
al., 1993), and has been found to be associated to apoptotic cell
death during development and tissue remodelling (Zhang et al.,
1997). The function of these markers in postmitotic neurones,
apart from participating in the induction of apoptosis, remains
unknown. 
The unscheduled re-entry into the cell cycle induced by NGF
in postmitotic cells could induce the activation of the p53
pathway. p53 is a known tumour supressor gene product that is
activated during situations of cellular stress, or after DNA
damage in cycling cells, and it induces apoptosis when
proliferative mechanisms are deregulated (for a review, see Jacks
and Weinberg, 1996; Levine, 1997). p53 has been implicated in
the signalling of sympathetic neurone death after NGF
withdrawal or activation of p75NTR with BDNF (Aloyz et al.,
1998). Cell death of sympathetic neurones due to NGF
deprivation has also been associated with the upregulation of
cyclin D1 (Freeman et al., 1994). Whether or not p53 might be
involved in the induction of apoptosis by NGF in our system
remains to be determined. 
BDNF as a factor that blocks NGF-induced cell death
BDNF has been described as an anti-apoptotic agent that
counterbalances the proapoptotic effect of p75NTR induced by
NGF (Davey and Davies, 1998; Yoon et al., 1998). This same
conclusion was obtained from the analysis of cell death taking
place in the chick retina after pharmacological treatment with
BDNF in vivo (Frade et al., 1997). In vitro, both the upregulation
of cyclin B2 and the subsequent death of retinal cells induced
by NGF were reversed by the addition of BDNF, demonstrating
that the same population of retinal cells induced to die by NGF
can be rescued by BDNF. The effect of BDNF was probably
mediated by TrkB, which is expressed by E5 retinal cells (Frade
et al., 1997), since the concentration of BDNF used in this study
was saturating for this receptor (Rodríguez-Tébar and Barde,
1988). 
In other paradigms of p75NTR-induced cell death,
neurotrophins other than BDNF have been shown to prevent
p75NTR-dependent neuronal death, as is the case for NGF in the
death of sympathetic neurones induced by BDNF (Bamji et al.,
1998). In addition, cell death is blocked by NT3 during the
neurogenesis phase of sensory neurones (ElShamy et al., 1998).
The authors of the latter work found that, in the absence of NT3,
a number of proliferation progression factors were upregulated
in sensory neurones, a fact that triggered cell death. Whether or
not NT3 prevents p75NTR-induced cell death in this system is
uncertain.
In conclusion, we propose a mechanism downstream of
p75NTR that is involved in the apoptotic signalling induced by
NGF upon interaction with this receptor. Evidence has been
presented to suggest that the unscheduled re-entry into the cell
cycle of postmitotic neurones is responsible, at least in part, for
the apoptotic effect of NGF. This phenomenon could be blocked
by BDNF, which would maintain the postmitotic state of the
neurones during the critical temporal window when the cell
decides to enter into the G0 phase. Therefore, a model could be
postulated whereby ‘neurotrophic’ agents, acting through Trk
receptors, would be required at certain critical developmental
time points to prevent the re-entry into the cell cycle of quiescent
neural cells induced by the binding of ‘proapoptotic’ agents to
p75NTR. 
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